We are live on
!
Find out more
CCA
Catalyst Capital Advisors Portfolio holdings
AUM
$5.37B
1-Year Est. Return
18.53%
This Fund
S&P 500
This Quarter
Est. Return
+2.73%
1 Year Est. Return
+18.53%
3 Year Est. Return
+51.12%
5 Year Est. Return
+53.74%
10 Year Est. Return
+223.58%
AUM
$872M
AUM Growth
+$19.8M
(+2.3%)
Cap. Flow
+$16.5M
Cap. Flow
% of AUM
1.89%
Top 10 Holdings %
Top 10 Hldgs %
18.4%
Holding
619
New
128
Increased
115
Reduced
79
Closed
181
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$20.3M |
| 2 |
Delta Air Lines
DAL
|
+$16.9M |
| 3 |
S
Sprint Corporation
S
|
+$15.9M |
| 4 |
Enovis
ENOV
|
+$14.7M |
| 5 |
SWN
Southwestern Energy Company
SWN
|
+$13.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$21.7M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$19.8M |
| 3 |
Flex
FLEX
|
+$17.9M |
| 4 |
Synchrony
SYF
|
+$15.3M |
| 5 |
Boston Scientific
BSX
|
+$14.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.85% |
| 2 | Industrials | 13.14% |
| 3 | Consumer Discretionary | 12.72% |
| 4 | Technology | 12.14% |
| 5 | Energy | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Alnylam Pharmaceuticals
ALNY
$36.4B
| $20.9M | 2.4% |
+200,250
| New | +$20.3M |
|
2
Freeport-McMoran
FCX
$84.5B
| $16.7M | 1.91% |
879,000
+229,000
| +35% | +$4.53M |
|
|
3
Delta Air Lines
DAL
$55.6B
| $16.6M | 1.91% |
370,305
+363,473
| +5,320% | +$16.9M |
|
|
ENDP
4
DELISTED
Endo International plc
ENDP
| $16.1M | 1.85% |
180,000
| – | – |
|
|
S
5
DELISTED
Sprint Corporation
S
| $16M | 1.83% |
+3,375,000
| New | +$15.9M |
|
6
Genuine Parts
GPC
$16.8B
| $15.9M | 1.82% |
170,500
-19,017
| -10% | -$1.83M |
|
7
Southern Copper
SCCO
$146B
| $15.3M | 1.76% |
566,324
+53,936
| +11% | +$1.44M |
|
|
8
Enovis
ENOV
$1.54B
| $14.4M | 1.66% |
+175,753
| New | +$14.7M |
|
9
Air Products & Chemicals
APD
$66.1B
| $14.4M | 1.65% |
102,781
+3,210
| +3% | +$444K |
|
10
Opko Health
OPK
$906M
| $14M | 1.61% |
988,924
+300,000
| +44% | +$3.9M |
|
11
Herc Holdings
HRI
$4.92B
| $13.3M | 1.52% |
204,400
+9,167
| +5% | +$612K |
|
12
Apple
AAPL
$4.8T
| $13.2M | 1.52% |
424,744
+90,792
| +27% | +$2.74M |
|
13
Fastenal
FAST
$51.4B
| $13.2M | 1.51% |
1,270,800
-202,000
| -14% | -$2.18M |
|
14
Prologis
PLD
$138B
| $13.1M | 1.5% |
300,195
+300,000
| +153,846% | +$13.1M |
|
|
MDVN
15
DELISTED
MEDIVATION, INC.
MDVN
| $12.9M | 1.48% |
+200,000
| New | +$11.5M |
|
16
Regions Financial
RF
$26.5B
| $12.7M | 1.46% |
+1,345,000
| New | +$12.7M |
|
|
SWN
17
DELISTED
Southwestern Energy Company
SWN
| $12.4M | 1.42% |
+535,000
| New | +$13.3M |
|
|
HES
18
DELISTED
Hess
HES
| $10.5M | 1.21% |
155,000
+154,879
| +127,999% | +$11M |
|
19
CF Industries
CF
$19B
| $10.5M | 1.2% |
185,000
| – | – |
|
20
Restaurant Brands International
QSR
$25.7B
| $9.89M | 1.13% |
257,515
+250,325
| +3,482% | +$9.98M |
|
|
MRO
21
DELISTED
Marathon Oil Corporation
MRO
| $9.27M | 1.06% |
355,000
+329,500
| +1,292% | +$8.94M |
|
22
Dominion Energy
D
$61.9B
| $9.21M | 1.06% |
130,000
-75,000
| -37% | -$5.56M |
|
23
KeyCorp
KEY
$25.2B
| $9.15M | 1.05% |
645,979
-681,950
| -51% | -$9.37M |
|
|
MJN
24
DELISTED
Mead Johnson Nutrition Company
MJN
| $9.05M | 1.04% |
+90,000
| New | +$9.08M |
|
25
Crown Castle
CCI
$34.1B
| $8.67M | 0.99% |
105,000
| – | – |
|
Similar funds
LP
ENV
KKRC
DPL
CBUSF
WL
DRZID
DWA
Catalyst Capital Advisors's Q1 2015 Portfolio in Review
As of Q1 2015, Catalyst Capital Advisors held 619 positions worth $872M, up 2.3% from $852M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Catalyst Capital Advisors's Q1 2015 filing shows 128 new, 115 increased, 79 reduced and 181 closed positions. Its largest new stake was Alnylam Pharmaceuticals: 200,250 shares worth $20.9M. The largest sale was Bausch Health, an estimated $21.7M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 15% a quarter earlier, followed by Industrials and Consumer Discretionary.
- Catalyst Capital Advisors's largest Q1 2015 buy was Alnylam Pharmaceuticals: 200,250 shares worth $20.9M.
- Catalyst Capital Advisors added most to Delta Air Lines in Q1 2015, an estimated $16.9M increase.
- Catalyst Capital Advisors's biggest Q1 2015 reduction was Bausch Health, cutting an estimated $21.7M.
- Catalyst Capital Advisors fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $19.8M.
- Catalyst Capital Advisors's ten largest holdings make up 18% of its $872M portfolio in Q1 2015.
- Catalyst Capital Advisors opened 128 new positions and closed 181 in Q1 2015.
- Catalyst Capital Advisors's portfolio value rose 2.3% quarter-over-quarter to $872M.
Based on Catalyst Capital Advisors's 13F filing for Q1 2015, filed 15 May 2015.